|
Events Column |
|
|
1/28
4:00 pm - 6:00 pm
CURE/Yale BioHaven Entrepreneurship Series: Advanced
Orthopedic Technologies/CardioPhotonics. Anlyan Center, Yale
Medical School, New Haven. more
|
|
|
2/25 4:00 pm - 6:00 pm
CURE/Yale BioHaven Entrepreneurship Series: Arbor Fuel. Kline
Geology Lab Building, Yale University, 210 Whitney Avenue, New
Haven. more
|
|
|
|
2/10
MIT Enterprise Forum of CT more
|
|
|
|
3/10
MIT Enterprise Forum of CT more
|
|
|
3/11
4:00 pm - 6:00pm
CURE/Yale BioHaven
Entrepreneurship Series: Jonathan Rothberg. Anlyan Center,
Yale Medical School, New Haven. more
|
|
|
|
4/7
MIT Enterprise Forum of CT more
|
|
|
4/8
4:00 pm - 6:00 pm
CURE/Yale BioHaven
Entrepreneurship Series: Amarin Pharma Inc. Anlyan Center,
Yale Medical School, New Haven. more
|
|
|
|
5/5
MIT Enterprise Forum of CT more
|
|
|
5/12
4:00 pm - 6:00 pm
CURE/Yale BioHaven
Entrepreneurship Series: JS Genetics. Anlyan Center, Yale
Medical School, New Haven. more
|
|
|
5/26
4:00 pm - 6:00 pm
CURE/Yale BioHaven
Entrepreneurship Series: Kolltan Pharmaceuticals. Anlyan
Center, Yale Medical School, New Haven. more
|
|
|
|
|
Bioscience
Roundtable Brings Leaders Together
From the desk of Paul
Pescatello, President and CEO of CURE
 The
Bioscience Business Roundtable event November 16 in West
Hartford brought together business and government leaders
concerned about the progress of bioscience in our state.
Speakers included U.S. Congressman Chris Murphy and
Connecticut Governor M. Jodi Rell, as well as State Senators
Jonathan Harris and Gary LeBeau and Lt. Governor Michael
Fedele.
For the full story |
|
|
Cara Presents at CURE/Yale BioHaven Series
Inaugurating the 2009-2010 CURE/Yale BioHaven Entrepreneurship seminar series was a presentation
October 21 by Cara Therapeutics Inc., an emerging biotechnology company in
Shelton focused on developing novel therapeutics to treat human diseases
associated with pain and inflammation.
For the full story
|
|
|
Helix Presents at CURE/Yale BioHaven Series
Continuing the 2009-2010 CURE/Yale BioHaven Entrepreneurship seminar series was a presentation
November 18 by Helix Therapeutics. Based in New Haven, Helix is a seed-stage
company dedicated to establishing cures for genetic diseases using
triplex-forming oligonucleotide (TFO) technology.
For the full story
|
|
|
Kolltan, BioRelix Draw 3Q CT Venture Capital
Venture capital investments
in Kolltan Pharmaceuticals, Inc. and BioRelix, Inc., both of
New Haven, totaled $8.6 million in the third quarter of
2009, according to The
MoneyTree® Report, issued quarterly by PricewaterhouseCoopers
and the National Venture Capital Association, based on data
from Thomson Reuters.
For the full story
|
|
|
Connecticut
Stem Cell Research Roundup
Connecticut
– the stem cell state
UConn researchers have generated 10 new stem
cell lines from the cells of patients with a genetic disorder called Angelman
syndrome, that enable them to watch how the disorder unfolds in petri dishes.
For the full story |
CURE Member News Digest
 454
Life Sciences collaborates on codfish sequencing
Alexion serves growing number
of patients
Amarin to increase Mystic local
workforce
Bayer HealthCare wins approval
for menstrual indication
Boehringer Ingelheim closes animal
health deal with Pfizer
Bristol-Myers Squibb reports
brain cancer progress
Cantor Colburn attorneys on
trademark committee
Connecticut Innovations invests in
Soft Tissue Regeneration
Danbury Hospital hosts Spirit of
Women weekend
GlaxoSmithKline reports H1N1
vaccine progress
Hartford Hospital gets grant for
statin effects research
Johnson
& Johnson names Mulcahy of Xerox to Board
Marinus names George Horner of
Sofinnova to Board
MannKind presents
insulin data in Vienna
NanoViricides raised
$4.3 million in equity financing
Pfizer reports
progress on arthritis drug
PhRMA
issues
statement on health care reform
UConn studies heart disease
medicines
Yale sequences protein-coding
genes in the genome
For
the full story |
|
